Related Experiment Videos
Stroke Recurrence and Long-Term Mortality in Patients Diagnosed with Cancer Following Stroke
Jin Kyo Choi1,2, Young Dae Kim1, Hyo Suk Nam1
1Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Medical Journal
|July 22, 2026
Summary
Cancer frequently develops in stroke survivors, increasing mortality risk. Early cancer detection in these patients is crucial for better outcomes.
Area of Science:
- Oncology
- Neurology
- Epidemiology
Background:
- Systemic cancer and ischemic stroke are leading causes of mortality.
- Shared risk factors include older age, smoking, obesity, and inflammation.
- Investigating cancer incidence post-stroke is critical for understanding patient outcomes.
Purpose of the Study:
- To determine the incidence of newly diagnosed cancers in patients who have survived an ischemic stroke.
- To analyze the outcomes, including cancer recurrence, recurrent stroke, and mortality, in this patient cohort.
Main Methods:
- Retrospective observational study of 5048 acute ischemic stroke patients (2010-2019).
- Exclusion of patients with cancer diagnosed within 30 days of stroke.
- Primary outcomes: new systemic cancer incidence, recurrent ischemic stroke, and mortality.
Main Results:
- Cancer was diagnosed in 4.79% of stroke survivors during a median 3.4-year follow-up.
- Cancer diagnosis was associated with male sex and older age.
- Cancer survivors faced a significantly higher mortality risk (HR, 2.57; P<0.001) but not a significantly higher risk of recurrent stroke.
Conclusions:
- Cancer diagnosis is frequent among ischemic stroke survivors.
- Developing cancer post-stroke is linked to increased mortality.
- Early cancer detection strategies in stroke survivors are warranted.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...